Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT-MVD: Clopidogrel + Aspirin vs Aspirin in Multi-Vessel Disease
NCT04624854Phase 4Completed
- Sponsor
- Harbin Medical University
- Start
- Oct 2020
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel in coronary artery disease (CAD), sponsored by Harbin Medical University. Started Oct 2020; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04624854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04624854.